Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Interleukin Inhibitors Market: By Type: L-17, IL-23, IL-1, IL-5, IL-6, Others; By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Interleukin Inhibitors Market Outlook
The global interleukin inhibitors market is expected to grow over the forecast period 2022-2027, growing at a CAGR of 13.5%. The interleukin inhibitors market is driven by the highly effective work of interleukin inhibitors in treating autoimmune disease.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Interleukin inhibitors are referred to as the immunosuppressive agents, which limit the activity of interleukins. Interleukin is a group of cytokines that are synthesized by lymphocytes, macrophages, monocytes, and certain other cells. Their role is to regulate the immune system.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The interleukin inhibitors market is segmented based on types and applications.
Based on type, the interleukin inhibitors market is divided into:
- L-17
- IL-23
- IL-1
- IL-5
- IL-6
- Others
Based on application, the interleukin inhibitors market is segmented into:
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Asthma
- Inflammatory Bowel Disease
- Others
The EMR report looks into the regional interleukin inhibitors markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The global interleukin inhibitors market is being driven by the highly effective work of interleukin inhibitors in treating autoimmune disease. The interleukin inhibitors market is aided by the numerous approved interleukin inhibitor molecules for treating autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn’s disease. Moreover, R&D is in progress over interleukin inhibitor molecules, and clinical trials for late-stage molecules is expected to impact market growth positively. Higher patient adherence to these drugs due to their higher affinity and specificity, as compared to other conventional approved autoimmune therapeutics, is predicted to increase their sales.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global interleukin inhibitors market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Novartis AG
- AbbVie Inc [NYSE: ABBV]
- Eli Lilly and Company
- Regeneron Pharmaceuticals, Inc.
- Johnson & Johnson Services, Inc
- F. Hoffmann-La Roche Ltd
- AstraZeneca
- Bausch Health
- GlaxoSmithKline plc
- Teva Pharmaceuticals Industries, Ltd.
- Others
The EMR report gives an in-depth insight into the interleukin inhibitors market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, Region |
| Breakup by Type | L-17, IL-23, IL-1, IL-5, IL-6, Others |
| Breakup by Application | Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Novartis AG [NOVN (SWX)], AbbVie Inc [ABBV (NYSE)], Eli Lilly and Company [LLY (NYSE)], Regeneron Pharmaceuticals, Inc. [REGN (NASDAQ)], Johnson & Johnson Services, Inc, F. Hoffmann-La Roche Ltd [ROG (SWX)], AstraZeneca [AZN (LON)], Bausch Health [BHC (TSE)], GlaxoSmithKline plc [GSK (LON)], Teva Pharmaceuticals Industries, Ltd. [TEVA (TLV)], Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Key Questions Answered in the Market Report:
- How has the global interleukin inhibitors market performed in the previous years (2017-2021)?
- What is the forecast assessment of the interleukin inhibitors market for 2022-2027?
- What are the major drivers in the historical (2017-2021) and forecast (2022-2027) periods?
- What are the major constraints in the historical (2017-2021) and forecast (2022-2027) periods?
- What are the major price indicators of the global industry?
- What are the major demand indicators of the global industry?
- What are the price trends of L-17, IL-23, IL-1, IL-5, and IL-6, among others, in the global industry?
- What are the import and export trends in the global interleukin inhibitors market?
- Who are the top importers and exporters of interleukin inhibitors in the industry globally?
- Who are the key manufacturers of L-17, IL-23, IL-1, IL-5, and IL-6, among others, in the global industry?
- What is the degree of competition in the global interleukin inhibitors market?
- What are the major events and developments taking place within the global industry?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Interleukin Inhibitors Market Analysis
8.1 Key Industry Highlights
8.2 Global Interleukin Inhibitors Historical Market (2017-2021)
8.3 Global Interleukin Inhibitors Market Forecast (2022-2027)
8.4 Global Interleukin Inhibitors Market by Type
8.4.1 L-17
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 IL-23
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 IL-1
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 IL-5
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 IL-6
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.4.6 Others
8.5 Global Interleukin Inhibitors Market by Application
8.5.1 Psoriasis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Psoriatic Arthritis
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Rheumatoid Arthritis
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Asthma
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Inflammatory Bowel Disease
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Interleukin Inhibitors Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Novartis AG
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 AbbVie Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Eli Lilly and Company
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Regeneron Pharmaceuticals, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Johnson and Johnson Services, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 F. Hoffmann-La Roche Ltd.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 AstraZeneca
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 Bausch Health
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 GlaxoSmithKline plc
12.2.9.1 Company Overview
12.2.9.2 Product Portfolio
12.2.9.3 Demographic Reach and Achievements
12.2.9.4 Certifications
12.2.10 Teva Pharmaceuticals Industries, Ltd.
12.2.10.1 Company Overview
12.2.10.2 Product Portfolio
12.2.10.3 Demographic Reach and Achievements
12.2.10.4 Certifications
12.2.11 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Interleukin Inhibitors Market: Key Industry Highlights, 2017 and 2027
2. Global Interleukin Inhibitors Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Interleukin Inhibitors Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Interleukin Inhibitors Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Interleukin Inhibitors Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Interleukin Inhibitors Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Interleukin Inhibitors Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Interleukin Inhibitors Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Interleukin Inhibitors Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Interleukin Inhibitors Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Interleukin Inhibitors Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Interleukin Inhibitors Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Interleukin Inhibitors Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Interleukin Inhibitors Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Interleukin Inhibitors Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Interleukin Inhibitors Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Interleukin Inhibitors Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Interleukin Inhibitors Market Structure
Analyst Review
Introduction
EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
- Value-added and infallible market intelligence.
- A holistic understanding of the current and expected market fluctuations through meticulously collected data.
- Verified information on the probable opportunities and risks in the present and forecasted markets.
- Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.
Assessment Approach
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
Price Assessment
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Market Assessment
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
Data Collection
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
Primary Research
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
Secondary Research
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Data Prioritisation
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Data Validation
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Exigent Data Assessment
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global contrast media/contrast agent market attained a value of USD 4.7 billion in 2020, driven by the increased incidences of chronic disorders. Aided by the rising demand for image-guided diagno...
The global medical foods market attained a value of USD 21 billion in 2020, driven by the increased incidences of chronic diseases. Aided by the rising awareness regarding the importance of medical fo...
The India hospital hand sanitisers market is expected to grow at a CAGR of 13.2% during the forecast period of 2022-2027 to reach nearly INR 902.3 crore by 2026.
The global sample preparation market is being driven by the rapid growth of the biotechnology and pharmaceuticals industries. Aided by the growing investments by key players in research and developmen...
The global medical foam market attained a value of about USD 27.1 billion in 2020, driven by the rising applications in medical devices. Aided by rising government investments, the market is expected ...
NEWSLETTER